The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Increases in Acute Hepatitis C Virus Infection Related to a Growing Opioid Epidemic and Associated Injection Drug Use, United States, 2004 to 2014
Open accessAbstract
Objectives. To compare US trends in rates of injection drug use (IDU), specifically opioid injection, with national trends in the incidence of acute HCV infection to assess whether these events correlated over time. Methods. We calculated the annual incidence rate and demographic and risk characteristics of reported cases of acute HCV infection using surveillance data from 2004 to 2014 and the annual percentage of admissions to substance use disorder treatment facilities reporting IDU for the same time period by type of drug injected and demographic characteristics. We then tested for trends. Results. The annual incidence rate of acute HCV infection increased more than 2-fold (from 0.3 to 0.7 cases/100 000) from 2004 to 2014, with significant increases among select demographic subgroups. Admissions for substance use disorder attributed to injection of heroin and prescription opioid analgesics increased significantly, with an almost 4-fold increase in prescription opioid analgesic injection. Significant increases in opioid injection mirrored those for reported cases of acute HCV infection among demographic subgroups. Conclusions. These findings strongly suggest that the national increase in acute HCV infection is related to the country’s opioid epidemic and associated increases in IDU.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
HIV Infection Linked to Injection Use of Oxymorphone in Indiana, 2014–2015
Peters, P. J., Pontones, P., Hoover, K. W., Patel, M. R., Galang, R. R., Shields, J., Blosser, S. J., Spiller, M. W., Combs, B., Switzer, W. M., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1515195 · Cited by 594
A systematic review of barriers to data sharing in public health
van Panhuis, W. G., Paul, P., Emerson, C., Grefenstette, J., Wilder, R., Herbst, A. J., Heymann, D., & Burke, D. S. (2014) · BMC Public Health · doi:10.1186/1471-2458-14-1144 · Cited by 579
Zibbell, J. E., Iqbal, K., Patel, R. C., Suryaprasad, A. G., Sanders, K. J., Moore-Moravian, L., Serrecchia, J., Blankenship, S., Ward, J. W., & Holtzman, D. J. (2015) · PubMed Central · Cited by 507
Self-citationSuryaprasad, A. G., White, J. Z., Xu, F., Eichler, B.-A., Hamilton, J., Patel, A., Hamdounia, S. B., Church, D. R., Barton, K., Fisher, C., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu643 · Cited by 500
Self-citationThorpe, L. E. (2002) · American Journal of Epidemiology · doi:10.1093/aje/155.7.645 · Cited by 444
Rising mortality associated with hepatitis C virus in the United States, 2003–2013
Ly, K. N., Hughes, E. M., Jiles, R. B., & Holmberg, S. D. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw111 · Cited by 358
Incidence of Neonatal Abstinence Syndrome — 28 States, 1999–2013
Ko, J. Y., Patrick, S. W., Tong, V. T., Patel, R., Lind, J. N., & Barfield, W. D. (2016) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6531a2 · Cited by 277
Self-citationHagan, H., Pouget, E. R., Des Jarlais, D. C., & Lelutiu-Weinberger, C. (2008) · American Journal of Epidemiology · doi:10.1093/aje/kwn237 · Cited by 222
Prevalence of Hepatitis C Virus Infection among Injection Drug Users in the United States, 1994–2004
Amon, J. J., Garfein, R. S., Ahdieh‐Grant, L., Armstrong, G. L., Ouellet, L. J., Latka, M. H., Vlahov, D., Strathdee, S. A., Hudson, S. M., Kerndt, P., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/588297 · Cited by 200
Bruneau, J., Roy, É., Arruda, N., Zang, G., & Jutras‐Aswad, D. (2012) · Addiction · doi:10.1111/j.1360-0443.2012.03803.x · Cited by 171
Cited by
Siegel, R. L., Miller, K. D., & Jemal, A. (2019) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21551 · Cited by 20,160
EASL Recommendations on Treatment of Hepatitis C 2018
Pawlotsky, J.-M., Negro, F., Aghemo, A., Berenguer, M., Dalgard, O., Dusheiko, G., Marra, F., Puoti, M., & Wedemeyer, H. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.03.026 · Cited by 2,827
Peery, A. F., Crockett, S. D., Murphy, C. C., Lund, J. L., Dellon, E. S., Williams, J. L., Jensen, E. T., Shaheen, N. J., Barritt, A. S., Lieber, S. R., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2018.08.063 · Cited by 1,619
EASL recommendations on treatment of hepatitis C: Final update of the series☆
Pawlotsky, J.-M., Negro, F., Aghemo, A., Berenguer, M., Dalgard, O., Dusheiko, G., Marra, F., Puoti, M., & Wedemeyer, H. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.08.018 · Cited by 1,252
Comparative effectiveness of different treatment pathways for opioid use disorder.
Wakeman, S. E., Larochelle, M. R., Ameli, O., Chaisson, C. E., McPheeters, J. T., Crown, W. H., Azocar, F., & Sanghavi, D. M. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.20622 · Cited by 995
“EXPOSURES One of 6 mutually exclusive treatment pathways, including (1) no treatment, (2) inpatient detoxification or residential services, (3) intensive behavioral health, (4) buprenorphine or methadone, (5) naltrexone, and (6) nonintensive behavioral health.”
BackgroundMethodThe rise of illicit fentanyls, stimulants and the fourth wave of the opioid overdose crisis
Ciccarone, D. (2021) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000717 · Cited by 987
Ghany, M. G., Morgan, T. R., & Panel, A. H. C. G. (2020) · Hepatology · doi:10.1002/hep.31060 · Cited by 955
Estimating Prevalence of Hepatitis C Virus Infection in the United States, 2013‐2016
Hofmeister, M. G., Rosenthal, E. M., Barker, L. K., Rosenberg, E. S., Barranco, M. A., Hall, E. W., Edlin, B. R., Mermin, J., Ward, J. W., & Ryerson, A. B. (2019) · Hepatology · doi:10.1002/hep.30297 · Cited by 486
Self-citationSpearman, C. W., Dusheiko, G. M., Hellard, M., & Sonderup, M. (2019) · The Lancet · doi:10.1016/s0140-6736(19)32320-7 · Cited by 404
Peiper, N. C., Clarke, S. D., Vincent, L. B., Ciccarone, D., Kral, A. H., & Zibbell, J. E. (2019) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2018.08.007 · Cited by 317
Self-citationPolysubstance use in the U.S. opioid crisis
Compton, W. M., Valentino, R. J., & DuPont, R. L. (2021) · Molecular Psychiatry · doi:10.1038/s41380-020-00949-3 · Cited by 288
Wong, R. J., & Singal, A. K. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.20294 · Cited by 253
Barocas, J. A., White, L. F., Wang, J., Walley, A. Y., LaRochelle, M. R., Bernson, D., Land, T., Morgan, J. R., Samet, J. H., & Linas, B. P. (2018) · American Journal of Public Health · doi:10.2105/ajph.2018.304673 · Cited by 164
Declining Life Expectancy in the United States: Missing the Trees for the Forest
Harper, S., Riddell, C. A., & King, N. B. (2021) · Annual Review of Public Health · doi:10.1146/annurev-publhealth-082619-104231 · Cited by 144
Preston, K. L., Kowalczyk, W. J., Phillips, K. A., Jobes, M. L., Vahabzadeh, M., Lin, J.-L., Mezghanni, M., & Epstein, D. H. (2018) · Psychopharmacology · doi:10.1007/s00213-018-4966-9 · Cited by 77
Pamplin, J. R., Rouhani, S., Davis, C. S., King, C., & Townsend, T. N. (2023) · American Journal of Public Health · doi:10.2105/ajph.2022.307037 · Cited by 59
Zhang, A. Y., Shrum, S., Williams, S., Petnic, S., Nadle, J., Johnston, H., Barter, D., Vonbank, B., Bonner, L., Hollick, R., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciz1061 · Cited by 54
Barbosa, C., Fraser, H., Hoerger, T. J., Leib, A., Havens, J. R., Young, A., Kral, A., Page, K., Evans, J., Zibbell, J., et al. (2019) · Addiction · doi:10.1111/add.14731 · Cited by 48
“HCV is primarily transmitted through injection drug use in the United States ([4]), with a seroprevalence above 50% among people who inject drugs (PWID) ([5-8]).”
BackgroundSelf-citationBarocas, J. A., Gai, M. J., Amuchi, B., Jawa, R., & Linas, B. P. (2020) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2020.108207 · Cited by 34
Bixler, D., Annambholta, P., Abara, W. E., Collier, M. G., Jones, J., Mixson-Hayden, T., Basavaraju, S. V., Ramachandran, S., Kamili, S., & Moorman, A. (2019) · American Journal of Transplantation · doi:10.1111/ajt.15352 · Cited by 29
Bartholomew, T. S., Feaster, D. J., Patel, H., Forrest, D. W., & Tookes, H. E. (2021) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2021.108344 · Cited by 21
Ciricillo, J., Myer, A., Yeboah-Korang, A., Osman, A., Rahim, F., Goldfarb, D. G., Sharma, Y., Louissaint, J., Sherman, K. E., & Fontana, R. J. (2025) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000003147 · Cited by 6
The boomer penalty: excess mortality among baby boomers in Canada and the United States
Acosta, E., Gagnon, A., Ouellette, N., Bourbeau, R. R., Nepomuceno, M., & van Raalte, A. A. (2020) · doi:10.4054/mpidr-wp-2020-003 · Cited by 5
Metadata
- Authors
- Zibbell, J. E., Asher, A. K., Patel, R. C., Kupronis, B., Iqbal, K., Ward, J. W., & Holtzman, D.
- Venue
- American Journal of Public Health
- Publisher
- American Public Health Association
- Published
- 2018-02
- Volume
- 108
- Issue
- 2
- Pages
- 175-181
- ISSN
- 0090-0036 (ISSN-L)
- 1541-0048
- OpenAlex
- W2778170606
- Cited by
- 698
- References
- 19
- FWCI
- 50.67
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.